Phathom Pharmaceuticals Inc (PHAT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $13.56
• Market Cap: $961.13M
• EPS: $-3.76
• 52-Week High: $18.31
• 52-Week Low: $2.21

Market Sentiment

Phathom Pharmaceuticals Inc currently has a Bullish sentiment score of 0.32.

About Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Florham Park, New Jersey, focusing on the development and commercialization of innovative therapies for gastrointestinal disorders. With a strong commitment to addressing unmet medical needs, Phathom is advancing a promising pipeline that includes novel treatment options, aiming to transform patient care in this critical therapeutic area. The company’s strategic emphasis on clinical development and potential p...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Phathom Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PHAT pay dividends?

Phathom Pharmaceuticals Inc (PHAT) does not currently pay a regular dividend.

What is PHAT's market cap?

Phathom Pharmaceuticals Inc (PHAT) has a market capitalization of $961.13M with a current stock price of $13.56.